$CINeutralLow

These Connecticut-based companies made this year's Fortune 500 list with revenue up to $275 billion

Fifteen Connecticut-headquartered companies made the 2026 Fortune 500, with revenues based on prior fiscal years. Cigna (Bloomfield) led at No. 14 with about $274.9 billion revenue. Amazon ranked No. 1 overall with nearly $717 billion. The Fortune 500 totaled about $21 trillion in revenue and $2 trillion in profits in 2025.

Low
Neutral
Fortune 500 ranking released this week; bundled company-specific items (CI leadership/FTC settlement, CHTR merger timing, SYF credit metrics, APH acquisitions).
Mostly neutral; CI includes regulatory/leadership items that could swing sentiment, while others are ranking/recap-heavy.

Fortune 500 ranking is a recap, but the article bundles multiple company-specific actions (CEO transition, layoffs, ACA exchange exit, FTC settlement) that can affect near-term sentiment and risk.

Cigna is highlighted as No. 14 in the Fortune 500 with 2025 revenue up ~11%, plus leadership retirement, layoffs, ACA exchange exit, and FTC insulin-PBM settlement details.

Low-to-medium near-term volatility risk; direction unclear without market reaction data.

Background

The article lists Connecticut-headquartered companies in the 2026 Fortune 500 (based on prior fiscal-year revenues) and adds a short rundown of selected recent developments for several firms.

Why it matters

Most of the piece is ranking/recap content, but it includes company-specific items for Cigna (leadership transition, layoffs, ACA exchange exit, FTC insulin-PBM settlement), Charter (merger timing), Synchrony (Q4 purchase volume and charge-offs), and Amphenol (acquisition-driven growth).

Market relevance

Trading relevance is concentrated in the bundled company-specific datapoints (CI regulatory/leadership actions, SYF credit metrics, APH acquisition-driven growth, CHTR merger timing). Pure ranking mentions are likely low incremental impact.

Market effects

Health insurers/PBMs face ongoing regulatory scrutiny (CI FTC insulin-PBM settlement) while telecom and consumer credit narratives (CHTR merger progress; SYF charge-offs) remain sentiment-sensitive.

Connecticut corporate footprint is emphasized; limited direct tradable regional effect beyond sector read-through.

Fortune 500 scale recap with limited incremental global macro signal; only CI/PM strategic/regulatory themes have broader policy relevance.

Alternative perspectives

Treat this primarily as a Fortune 500 recap: most price-relevant catalysts (CI FTC settlement, layoffs, ACA exchange exit, CHTR merger) may already be known, so incremental trading impact could be small.

Market reaction will depend on whether traders already priced the CI regulatory/leadership items and whether SYF’s charge-off trend is better or worse than consensus expectations—neither is provided here.

Key entities

  • The Cigna Group

    Connecticut-headquartered health insurer/PBM; No. 14 Fortune 500; includes leadership retirement, layoffs, ACA exchange exit, and FTC insulin-PBM settlement details.

  • Charter Communications

    Connecticut-headquartered cable/internet provider; No. 85; expects to complete Cox merger in 2H 2026.

  • Synchrony

    Store credit provider; No. 197; includes Q4 2025 purchase volume and net charge-off rate.

  • Amphenol

    Electronic components maker; No. 198; cites acquisition-driven revenue growth.

Related articles

$GEVLow

AI roads less traveled

Florida Trust says investors have focused on the “Magnificent 7” and OpenAI since ChatGPT’s 2022 launch, but that crowded exposure (35% of the S&P 500) may mean lower returns and higher risk. The firm highlights AI-linked opportunities beyond big tech, including industrials (S&P Industrials up ~18% YTD) tied to datacenter turbines and utilities facing a projected 44 GW US power shortfall through 2028. It cites Constellation Energy and Dominion Energy, plus datacenter REITs (Equinix, Digital Real

$NVDALow

Good News for NVIDIA, Amazon, and Micron Investors: New Research Shows Trillion-Dollar Stocks May 10X

Coatue’s Thomas Laffont, discussed on the All-In podcast, said trillion-dollar stocks such as NVIDIA and Amazon have 30%+ odds of reaching $10 trillion, citing “filters” like dominant market position and durable earnings. The article notes Micron’s cloud memory revenue nearly doubled to $5.28B with 66% gross margins, while analyst targets and insider selling suggest near-term caution. It also flags antitrust enforcement as a key risk for NVIDIA and Amazon.

$MSFTLow

Billionaire Investor Bill Ackman: Buying Microsoft, Meta, and Amazon Today Could Be Like Adding Buffett’s Berkshire Hathaway 25 Years Ago

Bill Ackman of Pershing Square said on the All-In Podcast that mega-cap stocks are being undervalued like Berkshire Hathaway was during the dot-com peak. He cited holdings in Microsoft, Meta and Amazon, noting Microsoft’s AI revenue run rate exceeded $37 billion (up 123% YoY) and Meta’s Q1 revenue rose 33.1%. He warned niche software charging about $30,000/year faces AI replication risk.

$GOOGLMed

Alphabet storms markets with historic US$90bn equity raise

Alphabet, Google’s parent, announced a near US$50bn equity raise with another US$40bn via an at-the-market program, to fund data centres and AI infrastructure. The company agreed a US$10bn Berkshire Hathaway private placement and a US$34.75bn underwritten public offer, upsized from US$30bn; with greenshoes, proceeds reached US$39.96bn. Alphabet said AI capex could reach US$190bn this year.

$ETHLow

Benzinga

Fundstrat’s Tom Lee told investors at a Paris conference that a “crypto spring” is already underway, citing potential oil-price declines from an Iran war ceasefire, Ethereum’s inverse correlation to oil, and reduced Ethereum Foundation holdings (down to ~0.1% of supply). He also cited Bitmine’s staking rewards, Russell 1000 inclusion (June 26), and tokenization/AI. He predicted ETH could reach $22,000 and Bitmine stock $500.